巴尔化学
BCPC
170.73
+0.20
+0.12%
巴尔化学
US · BCPC
#2068 按市值排名
上市于 1970
170.73
+0.20
+0.12%
实时 - 追踪5344个代码 - 心跳于520秒前
· 2026-10-16 20:01
✦ 量化股权信号 计算方式说明
增持
- 最近一期（2026/Q3）披露持股的机构数量减少了4家。
- 机构持股总比例上升了0.1个百分点。
机构持股
- 机构持股比例
- 92.19% +0.13pp
- 机构数量
- 491 -4
- 数据截至
- 2026/Q3 较上一报告期
持股变动 vs 资金流向
方向分歧机构在上一报告期增持了股份，同时该股在最近20个交易日的主力资金呈净流出——两者方向出现分歧。
机构持股变动数据按季度发布且存在滞后；资金流向数据为每日更新。请将其作为方向性的交叉验证参考，而非精确的择时信号。
持股人类型
Mutual Fund79.06%
Hedge Fund6.35%
Public Company2.05%
Government Pension Fund1.53%
Sovereign Wealth Fund1.34%
Private Company0.75%
Insurance Company0.73%
Individual/Insider0.57%
Family Office/Trust0.20%
Other7.42%
主要股东 截至 2026-06-30
BlackRock
15.57% · 4.96M 股
Vanguard Portfolio Management, LLC
6.97% · 2.22M 股
Vanguard Capital Management, LLC
5.25% · 1.68M 股
State Street Global Advisors
4.02% · 1.28M 股
Geode Capital Management, LLC
3.52% · 1.12M 股
Conestoga Capital Advisors, LLC
3.41% · 1.09M 股
Wasatch Advisors LP
3.30% · 1.05M 股
Nationwide Fund Advisors
2.08% · 664.59K 股
Eaton Vance Management
1.97% · 627.49K 股
First Trust Advisors L.P.
1.94% · 617.23K 股
条形长度是相对于此处列出的最大股东而言，并非相对于公司100%股权。
内部人持股
共追踪50份申报 · 27次买入 · 21次卖出
| 姓名 | 职务 | 持股比例 |
|---|---|---|
| Theodore Harris | Chairperson & CEO | 0.23% |
| Carl Bengtsson | Chief Financial Officer | 0.07% |
| Job Van Gunsteren | -- | 0.03% |
| M. Tignor | Chief Human Resources Officer | 0.03% |
| Martin Reid | Senior VP & Chief Supply Chain Officer | 0.03% |
| David Fischer | Independent Director | 0.02% |
| William Backus | VP & CAO | 0.02% |
| Matthew Wineinger | Lead Independent Director | 0.02% |
| Michael Sestrick | Chief Technology Officer | 0.02% |
| Daniel Knutson | Independent Director | 0.02% |
内部人交易 最近的 Form 4 申报记录
| 日期 | 姓名 | 职务 | 类型 | 股数 | 价格 |
|---|---|---|---|---|---|
| 2026-03-31 | Erin Gilson | Vice President | Initial Statement of Beneficial | 0 | -- |
| 2026-02-11 | Theodore Harris | Chairperson & CEO | Sale to Issuer | -10,202 | $177.49–178.68 |
| 2026-02-11 | William Backus | VP & CAO | Sale to Issuer | -935 | $177.49–178.68 |
| 2026-02-11 | M. Tignor | Chief Human Resources Officer | Sale to Issuer | -1,156 | $177.49–178.68 |
| 2026-02-11 | Frederic Boned | Senior VP and GM of Human Nutrition & Health | Sale to Issuer | -1,354 | $177.49–178.68 |
| 2026-02-11 | Carl Bengtsson | Chief Financial Officer | Sale to Issuer | -2,718 | $177.49–178.68 |
| 2026-02-11 | Hatsuki Miyata | General Counsel | Sale to Issuer | -1,058 | $177.49–178.68 |
| 2026-02-11 | Job Van Gunsteren | -- | Sale to Issuer | -814 | $177.49–178.68 |
| 2026-02-11 | Martin Reid | Senior VP & Chief Supply Chain Officer | Sale to Issuer | -1,201 | $177.49–178.68 |
| 2026-02-10 | Daniel Knutson | Independent Director | Other Acquisition | +870 | -- |
| 2026-02-10 | Theodore Harris | Chairperson & CEO | Other Acquisition | +25,641 | -- |
| 2026-02-10 | Theodore Harris | Chairperson & CEO | Other Derivative Acquisition | +26,900 | $178.68 |
| 2026-02-10 | David Fischer | Independent Director | Other Acquisition | +870 | -- |
| 2026-02-10 | Matthew Wineinger | Lead Independent Director | Other Acquisition | +870 | -- |
| 2026-02-10 | Olivier Rigaud | Independent Director | Other Acquisition | +870 | -- |
| 2026-02-10 | William Backus | VP & CAO | Other Acquisition | +2,154 | -- |
| 2026-02-10 | William Backus | VP & CAO | Other Derivative Acquisition | +1,800 | $178.68 |
| 2026-02-10 | Kathleen Fish | Independent Director | Other Acquisition | +870 | -- |
| 2026-02-10 | M. Tignor | Chief Human Resources Officer | Other Acquisition | +3,129 | -- |
| 2026-02-10 | M. Tignor | Chief Human Resources Officer | Other Derivative Acquisition | +4,400 | $178.68 |
Form 4 申报记录，每家公司显示最新的一批。"Other Derivative Acquisition"（其他衍生品获取）类目多为限制性股票/期权归属，并非公开市场买入——具体类型见"类型"列。
报价时间 2026-10-16 20:01:11 · 仅供参考，不构成投资建议，也未考虑您的具体情况。
巴尔化学 讨论区 0 条评论